Streptococcus agalactiae (GBS)

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is a significant cause of neonatal infections, including sepsis, meningitis, and pneumonia. It can also lead to complications in pregnant women and immunocompromised individuals. Early detection is critical, especially for prenatal screening and intrapartum risk assessment.
Streptococcus agalactiae PCR kits based on real-time PCR technology offer a sensitive and specific method for detecting S. agalactiae DNA in human samples. These molecular diagnostics tools offer accurate and reproducible results in routine and specialized laboratory workflows. Available in CE IVD-marked formats for diagnostic use and as research use only (RUO) versions, these PCR assays support applications such as maternal screening, neonatal infection monitoring, and microbiological research from clinical samples.